Bristol-Myers Squibb Co
BRM
Company Profile
Business description
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Contact
Route 206 and Province Line Road
Princeton
New JerseyNJ08543
USAT: +1 609 252-4621
E: timothy.power@bms.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
34,100
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,959.70 | 106.00 | 1.35% |
| CAC 40 | 7,298.31 | 193.51 | 2.72% |
| DAX 40 | 21,023.53 | 649.43 | 3.19% |
| Dow JONES (US) | 40,716.16 | 503.45 | 1.25% |
| FTSE 100 | 8,153.94 | 189.76 | 2.38% |
| HKSE | 21,417.40 | 502.71 | 2.40% |
| NASDAQ | 17,035.19 | 310.74 | 1.86% |
| Nikkei 225 | 33,982.36 | 396.78 | 1.18% |
| NZX 50 Index | 12,107.54 | 88.41 | 0.74% |
| S&P 500 | 5,449.21 | 85.85 | 1.60% |
| S&P/ASX 200 | 7,748.60 | 102.10 | 1.34% |
| SSE Composite Index | 3,262.81 | 24.58 | 0.76% |